BNF:

11.6

Status:

Do Not Prescribe (DNP), Grey - after consultant/specialist recommendation

Decision Date:

July 2019

Comments

GREY after consultant/specialist initiation: 2nd line prostaglandin analogue. (40micrograms/ml eye drops). Cost effective to prescribe generically (Decision date - July 2022)

DNP: Not to be prescribed by brand - Travatan (Decision date - August 2019)

Do Not Prescribe (DNP) Drug Classifications

• 5: Less cost-effective than current standard therapy

search again